| Business Summary | | STAAR
Surgical
Company
is
a
developer,
manufacturer
and
global
distributor
of
products
used
by
ophthalmologists
and
other
eye
care
professionals
to
improve
or
correct
vision
in
patients
suffering
from
refractive
conditions,
cataracts
and
glaucoma.
The
Company's
products
serve
the
Refractive
Vision
Correction,
Cataract
Treatment,
and
Glaucoma
Treatment
segments
of
the
ophthalmic
market.
The
Company's
products
are
designed
to
improve
treatment
results,
minimize
patient
risk
and
discomfort
and,
where
possible,
simplify
ophthalmic
procedures
for
the
surgeon
and
the
patient.
The
Company
sells
its
products
worldwide,
principally
to
ophthalmologists,
surgical
centers,
hospitals,
managed
care
providers,
health
maintenance
organizations
and
group
purchasing
organizations. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | STAAR
Surgical
Company
develops,
manufactures
and
distributes
foldable
intraocular
lenses,
and
medical
devices
used
in
connection
with
cataract
surgery.
For
the
six
months
ended
6/29/01,
total
revenues
fell
4%
to
$25.9
million.
Net
loss
fell
76%
to
$4.4
million.
Revenues
reflect
unfavorable
exchange
rates
and
lower
IOLs
sales.
Lower
loss
reflects
the
absence
of
a
$13.8
million
restructuring
charge
and
a
$4.7
million
equity
loss
of
joint
venture. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| David Bailey, 45 Chairman,
Pres, CEO | $308K | John Santos, 45 CFO | 192K | Gunther Roepstorff, 55 Exec.
VP, Sales--International | 240K | Richard Simmons Sr.
VP, Global Operations and Pres, STAAR Surgical AG | -- | Michael Chandler, 56 VP,
Manufacturing | -- | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|